Cargando…
Thrombosis Prevention and Anticoagulation Management in the Pediatric Patient with Congenital Heart Disease
Thrombosis is one of the most frequent complications affecting children with congenital heart disease (CHD). Palliative and reparative cardiac surgeries are some of the main players contributing to the thrombosis risk in this patient population. Additional risk factors related to the CHD itself (e.g...
Autores principales: | Abdelghani, Eman, Cua, Clifford L., Giver, Jean, Rodriguez, Vilmarie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555036/ https://www.ncbi.nlm.nih.gov/pubmed/34184214 http://dx.doi.org/10.1007/s40119-021-00228-4 |
Ejemplares similares
-
Thrombosis Complications in Pediatric Acute Lymphoblastic Leukemia: Risk Factors, Management, and Prevention: Is There Any Role for Pharmacologic Prophylaxis?
por: Rodriguez, Vilmarie
Publicado: (2022) -
Drive-Through Anticoagulation Clinic During the COVID-19 Pandemic
por: Giver, Jean, et al.
Publicado: (2022) -
Ortner’s Syndrome in an Infant With Congenital Heart Disease
por: Murillo-Deluquez, Marcelino, et al.
Publicado: (2022) -
Cerebral sinovenous thrombosis in pediatric hemolytic uremic syndrome
por: Wyatt, Kirk D., et al.
Publicado: (2020) -
Thrombosis Prevention without Anticoagulation
por: Schmaier, Alvin H.
Publicado: (2014)